Abstract
Patients have many concerns when diagnosed with hairy cell leukemia (HCL). Their ultimate concern is whether they will be cured. Although purine nucleoside analogs have been very effective in the treatment of HCL, some patients do not respond to these therapies and many relapse after initial treatment. From a patient's point of view, it is gratifying to know that researchers continue their efforts to develop more effective treatments with minimal side effects. By forming the Hairy Cell Leukemia Consortium, these researchers seek to educate patients and doctors around the world and continue their quest for a cure for hairy cell leukemia.
Keywords:
Potential conflict of interest:
A disclosure form provided by the author is available with the full text of this article at www.informahealthcare.com/lal.